Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q95967206
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235822.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q95967206
|
024
|
|
|
‡a
0000-0002-6608-4695
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q95967206
|
100
|
0 |
|
‡a
Andressa Souza
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Andressa Souza
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Effects of gestational and breastfeeding caffeine exposure in adenosine a1 agonist-induced antinociception of infant rats
|
670
|
|
|
‡a
Author's Single exercise stress reduces central neurotrophins levels and adenosine A1 and A2 receptors expression, but does not revert opioid-induced hyperalgesia in rats
|
670
|
|
|
‡a
Author's The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor
|
670
|
|
|
‡a
Author's Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System
|
909
|
|
|
‡a
(orcid) 0000000266084695
‡9
1
|
919
|
|
|
‡a
effectsofgestationalandbreastfeedingcaffeineexposureinadenosinea1agonistinducedantinociceptionofinfantrats
‡A
Effects of gestational and breastfeeding caffeine exposure in adenosine a1 agonist-induced antinociception of infant rats
‡9
1
|
919
|
|
|
‡a
centralsensitizationinventoryvalidatedandadaptedforabrazilianpopulationpsychometricpropertiesanditsrelationshipwithbrainderivedneurotrophicfactor
‡A
The Central Sensitization Inventory validated and adapted for a Brazilian population: psychometric properties and its relationship with brain-derived neurotrophic factor
‡9
1
|
919
|
|
|
‡a
uliginosinbapossiblenewanalgesicdrugactsbymodulatingtheadenosinergicsystem
‡A
Uliginosin B, a Possible New Analgesic Drug, Acts by Modulating the Adenosinergic System
‡9
1
|
919
|
|
|
‡a
singleexercisestressreducescentralneurotrophinslevelsandadenosinea1anda2receptorsexpressionbutdoesnotrevertopioidinducedhyperalgesiainrats
‡A
Single exercise stress reduces central neurotrophins levels and adenosine A1 and A2 receptors expression, but does not revert opioid-induced hyperalgesia in rats
‡9
1
|
996
|
|
|
‡2
LC|no2022131690
|
996
|
|
|
‡2
BLBNB|000360725
|
996
|
|
|
‡2
BLBNB|000360344
|
996
|
|
|
‡2
PTBNP|211749
|
996
|
|
|
‡2
LC|n 84104225
|
996
|
|
|
‡2
PTBNP|1525163
|
996
|
|
|
‡2
J9U|987007341189405171
|
996
|
|
|
‡2
LIH|LNB:CE_t_1;=BT
|
996
|
|
|
‡2
ISNI|0000000383757385
|
996
|
|
|
‡2
LC|n 83057105
|
996
|
|
|
‡2
ISNI|0000000045026192
|
996
|
|
|
‡2
PTBNP|1807495
|
996
|
|
|
‡2
LC|no2007104394
|
996
|
|
|
‡2
BNF|13465773
|
996
|
|
|
‡2
CAOONL|ncf11168433
|
996
|
|
|
‡2
NII|DA03134193
|
996
|
|
|
‡2
ISNI|000000044076040X
|
996
|
|
|
‡2
BLBNB|000603125
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|